Treatment with the FAK inhibitor PF-573228 significantly decreased p-FAK and p-CREB levels and YAP mRNA and protein levels (Figure 3C and Figure S4A), suggesting that YAP expression is regulated by FAK/CREB signaling in chemoresistant BC cells. Here, CREB1 is linked to breast cancer.